Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-065702
Filing Date
2025-07-03
Accepted
2025-07-03 13:15:54
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2519766-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2519766-2_3seq1.xml 3 5969
  Complete submission text file 0001104659-25-065702.txt   7406
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIQUIDIA CORP 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address
Krepp Sarah (Reporting) CIK: 0002074990 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39724 | Film No.: 251104739